Related Experiment Video
Updated: Dec 1, 2025
09:47
Anesthesia and Intubation of Preadolescent Mouse Pups for Cardiothoracic Surgery
Published on: June 2, 2022
2.6K
Caffeine for preterm infants: Fixed standard dose, adjustments for age or high dose?
Vivek Saroha1, Ravi Mangal Patel1
1Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, 2015 Uppergate Dr. NE, Division of Neonatology, Atlanta, GA, 30322, USA.
Seminars in Fetal & Neonatal Medicine
|November 10, 2020
Summary
Caffeine citrate effectively treats apnea of prematurity. High-dose caffeine may offer benefits for bronchopulmonary dysplasia and extubation but requires further study due to potential risks like seizures.
Area of Science:
- Neonatology
- Pharmacology
- Pediatric Critical Care
Background:
- Caffeine citrate is a standard treatment for apnea of prematurity.
- It offers benefits such as reduced respiratory morbidity and motor impairment.
Purpose of the Study:
- To review the efficacy and safety of standard and alternative caffeine dosing strategies.
- To evaluate the role of high-dose caffeine and routine dose adjustments.
Main Methods:
- Review of current evidence on caffeine dosing for apnea of prematurity.
- Analysis of studies comparing standard, high-dose, and adjusted caffeine regimens.
Main Results:
- High-dose caffeine may reduce bronchopulmonary dysplasia and extubation failure.
- Potential risks of high-dose caffeine include cerebellar hemorrhage and seizures.
- Dose adjustments to 8 mg/kg/24h may maintain therapeutic effects.
Conclusions:
- High-dose caffeine shows potential benefits but carries increased risks.
- Further clinical trials are necessary before routine adoption of high-dose caffeine.
- Optimizing caffeine dosing is crucial for managing apnea of prematurity.
Related Concept Videos
01:29Drug Dosing: Infants and Children
121
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
121
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
120
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
120
01:21Factors Affecting Drug Response: Overview
2.7K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.7K
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
146
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
146
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
99
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
99
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
130
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
130